Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (1942)	9/30/1997 3:24:00 PM
From: Izzy	of 6136

Henry, I appreciate your input to this thread. As far as I know, Jesse Essinger is a staff reporter, not a physician. It is interesting to me how a nonphysician interprets experimental/clinical medicine when they have no medical training whatsoever. For example, reference is made to "patients fail to take their medication, or resistance is developed, or when doctors don't prescribe correctly." In clinical trials, as you know, the patients are given the meds. Clinically, few patients can afford them (many, if not most, are "uninsured"). HIV/AIDS patients are very cooperative in taking meds and the doctors certainly know how to prescribe correctly.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next